References
- SiegelRMillerKJemalAStatisticsCCA Cancer J Clin2015201563529
- FukudaYSchuetzJDABC transporters and their role in nucleoside and nucleotide drug resistanceBiochem Pharmacol20128381073108322285911
- PrattSShepardRLKandasamyRAJohnstonPAPerryWDantzigAHThe multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolitesMol Cancer Ther20054585586315897250
- ParkSShimizuCShimoyamaTGene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patientsBreast Cancer Res Treat200699191716752223
- FletcherJIHaberMHendersonMJNorrisMDABC transporters in cancer: more than just drug efflux pumpsNat Rev Cancer201010214715620075923
- LiBChenHWuNZhangWJShangLXDeregulation of miR-128 in ovarian cancer promotes cisplatin resistanceInt J Gynecol Cancer20142481381138825248111
- HamamotoJYasudaHAizawaKNon-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitorsOncol Lett20171433559356528927112
- MourskaiaAAAmirEDongZABCC5 supports osteoclast formation and promotes breast cancer metastasis to boneBreast Cancer Res2012146R14923174366
- BushatiNCohenSMmicroRNA functionsAnnu Rev Cell Dev Biol20072317520517506695
- CarthewRWSontheimerEJOrigins and mechanisms of miRNAs and siRNAsCell2009136464265519239886
- LiHYangBBStress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2Oncotarget20123121653166823391506
- ZhangHLiSYangXQiaoBZhangZXuYmiR-539 inhibits prostate cancer progression by directly targeting SPAG5J Exp Clin Cancer Res2016356027037000
- ZhangHQiCWangAPrognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancerJ Exp Clin Cancer Res2013327724422979
- KimJYuWKovalskiKOssowskiLRequirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assayCell19989433533629708737
- ArredouaniMSLuBBhasinMIdentification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancerClin Cancer Res200915185794580219737960
- GrassoCSWuYMRobinsonDRThe mutational landscape of lethal castration-resistant prostate cancerNature2012487740623924322722839
- LuoJHYuYPCieplyKGene expression analysis of prostate cancersMol Carcinog2002331253511807955
- TomlinsSAMehraRRhodesDRIntegrative molecular concept modeling of prostate cancer progressionNat Genet2007391415117173048
- WallaceTAPrueittRLYiMTumor immunobiological differences in prostate cancer between African-American and European-American menCancer Res200868392793618245496
- ChandranURMaCDhirRGene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic processBMC Cancer200776417430594
- HolzbeierleinJLalPLatulippeEGene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistanceAm J Pathol2004164121722714695335
- VaramballySYuJLaxmanBIntegrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progressionCancer Cell20058539340616286247
- YuYPLandsittelDJingLGene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancyJ Clin Oncol200422142790279915254046
- LapointeJLiCHigginsJPGene expression profiling identifies clinically relevant subtypes of prostate cancerProc Natl Acad Sci U S A2004101381181614711987
- LatulippeESatagopanJSmithAComprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic diseaseCancer Res200262154499450612154061
- TaylorBSSchultzNHieronymusHIntegrative genomic profiling of human prostate cancerCancer Cell2010181112220579941
- NakagawaTKollmeyerTMMorlanBWA tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapyPLoS One200835e231818846227
- SinghDFebboPGRossKGene expression correlates of clinical prostate cancer behaviorCancer Cell20021220320912086878
- VanajaDKChevilleJCIturriaSJYoungCYTranscriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progressionCancer Res200363143877388212873976
- WelshJBSapinosoLMSuAIAnalysis of gene expression identifies candidate markers and pharmacological targets in prostate cancerCancer Res200161165974597811507037
- TakeiYTakigahiraMMiharaKTarumiYYanagiharaKThe metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancerCancer Res20117141442145321169410
- SpahnMKneitzSScholzCJExpression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrenceInt J Cancer2010127239440319585579
- LeungAKSharpPAMicroRNA functions in stress responsesMol Cell201040220521520965416